Cargando…
Radiomics for personalised medicine: the long road ahead
Radiomics is well placed to make clinically effective and cost-effective contributions to cancer care as a decision-making tool for personalised medicine. However, a systematic evaluative framework needs to be established so that these benefits can be demonstrated with confidence.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109132/ https://www.ncbi.nlm.nih.gov/pubmed/31937924 http://dx.doi.org/10.1038/s41416-019-0699-8 |
| _version_ | 1783512895723667456 |
|---|---|
| author | Miles, Kenneth |
| author_facet | Miles, Kenneth |
| author_sort | Miles, Kenneth |
| collection | PubMed |
| description | Radiomics is well placed to make clinically effective and cost-effective contributions to cancer care as a decision-making tool for personalised medicine. However, a systematic evaluative framework needs to be established so that these benefits can be demonstrated with confidence. |
| format | Online Article Text |
| id | pubmed-7109132 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71091322021-01-15 Radiomics for personalised medicine: the long road ahead Miles, Kenneth Br J Cancer Editorial Radiomics is well placed to make clinically effective and cost-effective contributions to cancer care as a decision-making tool for personalised medicine. However, a systematic evaluative framework needs to be established so that these benefits can be demonstrated with confidence. Nature Publishing Group UK 2020-01-15 2020-03-31 /pmc/articles/PMC7109132/ /pubmed/31937924 http://dx.doi.org/10.1038/s41416-019-0699-8 Text en © Cancer Research UK 2020 https://creativecommons.org/licenses/by/4.0/Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0). |
| spellingShingle | Editorial Miles, Kenneth Radiomics for personalised medicine: the long road ahead |
| title | Radiomics for personalised medicine: the long road ahead |
| title_full | Radiomics for personalised medicine: the long road ahead |
| title_fullStr | Radiomics for personalised medicine: the long road ahead |
| title_full_unstemmed | Radiomics for personalised medicine: the long road ahead |
| title_short | Radiomics for personalised medicine: the long road ahead |
| title_sort | radiomics for personalised medicine: the long road ahead |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109132/ https://www.ncbi.nlm.nih.gov/pubmed/31937924 http://dx.doi.org/10.1038/s41416-019-0699-8 |
| work_keys_str_mv | AT mileskenneth radiomicsforpersonalisedmedicinethelongroadahead |